What do systematic reviews say?

Assistive technology for vision improvement interventions vs usual care or attention control

The review found no eligible studies for this question.

• Environmental interventions for preventing falls in older people living in the community 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Assistive technology for vision improvement interventions vs usual care or attention control

• Environmental interventions for preventing falls in older people living in the community 2023 · Cochrane Headline outcomes only
  0.93 [0.48, 1.82]
  1 study · 276 participants
  Very low

Assistive technology for vision improvement interventions vs usual care or attention control

Assistive technology for vision improvement interventions showed no clear difference in health‐related quality of life 1 trial of single‐lens glasses… compared with usual care or attention control (low certainty).

• Environmental interventions for preventing falls in older people living in the community 2023 · Cochrane Headline outcomes only
  MD 0.4
  1 study · 597 participants
  Low

Assistive technology for vision improvement interventions vs usual care or attention control

Assistive technology for vision improvement interventions showed no clear difference in adverse events Falls while switching glasses compared with usual care or attention control (low certainty).

• Environmental interventions for preventing falls in older people living in the community 2023 · Cochrane Headline outcomes only
  RR 1 [0.98, 1.02]
  1 study · 597 participants
  Low

Assistive technology for vision improvement interventions vs usual care or attention control

Assistive technology for vision improvement interventions showed no clear difference in rate of falls (falls per person‐years) compared with usual care or attention control (low certainty).

• Environmental interventions for preventing falls in older people living in the community 2023 · Cochrane Headline outcomes only
  Rate ratio 1.12 [0.84, 1.5]
  3 studies · 1489 participants
  Low

Assistive technology for vision improvement interventions vs usual care or attention control

Assistive technology for vision improvement interventions showed no clear difference in number of people who experienced 1 or more falls compared with usual care or attention control (low certainty).

• Environmental interventions for preventing falls in older people living in the community 2023 · Cochrane Headline outcomes only
  RR 1.09 [0.79, 1.5]
  3 studies · 1489 participants
  Low

Summary of findings table ‐ Simple educational intervention vs usual care

• Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 241 participants
  Moderate

Summary of findings table ‐ Simple educational intervention vs usual care

• Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 813 participants
  Low

Summary of findings table ‐ Simple educational intervention vs usual care

• Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 463 participants
  Low

Summary of findings table ‐ Simple educational intervention vs usual care

• Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings 2023 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 1202 participants
  Very low

Summary of findings table ‐ Simple educational intervention vs usual care

• Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 1483 participants
  Very low

Summary of findings table ‐ Simple educational intervention vs usual care

The review found no eligible studies for this question.

• Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 38 participants
  Very low

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

It is very uncertain whether interventions (vitamin B1, mefenamic acid, tranexamic acid) changes side effects: gastrointestinal disturbances (diarrhoea, lower… compared with placebo or active comparators (desmopressin, sodium diclofenac,… (very low certainty).

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  OR 4.69 [1.2, 18.44]
  1 study · 38 participants
  Very low

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 100 participants
  Low
• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 24 participants
  Very low

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 100 participants
  Low
• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 110 participants
  Low

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 100 participants
  Low
• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 290 participants
  Very low

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

Interventions (vitamin B1, mefenamic acid, tranexamic acid) showed no clear difference in side effects: headache compared with placebo or active comparators (desmopressin, sodium diclofenac,… (low certainty).

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  OR 0.58 [0.18, 1.92]
  1 study · 100 participants
  Low

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

Interventions (vitamin B1, mefenamic acid, tranexamic acid) showed no clear difference in side effects: vomiting compared with placebo or active comparators (desmopressin, sodium diclofenac,… (low certainty).

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  OR 0.74 [0.25, 2.18]
  1 study · 100 participants
  Low

Interventions (vitamin B1, mefenamic acid, tranexamic acid) vs placebo or active comparators (desmopressin, sodium diclofenac, flavonoids)

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 participants
  GRADE not reported